574 related articles for article (PubMed ID: 30803129)
1. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2.
Qian K; Liu G; Tang Z; Hu Y; Fang Y; Chen Z; Xu X
Arch Biochem Biophys; 2017 Feb; 615():1-9. PubMed ID: 28034643
[TBL] [Abstract][Full Text] [Related]
4. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1.
Jiang X; Zhou Y; Sun AJ; Xue JL
J Cell Physiol; 2018 Nov; 233(11):8558-8566. PubMed ID: 29323713
[TBL] [Abstract][Full Text] [Related]
5. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
6. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer.
Mohamed WA; Schaalan MF; Ramadan B
J Cell Biochem; 2019 Aug; 120(8):13464-13477. PubMed ID: 30945348
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
9. Huaier Extract Inhibits Breast Cancer Progression Through a LncRNA-H19/MiR-675-5p Pathway.
Wang J; Wang X; Chen T; Jiang L; Yang Q
Cell Physiol Biochem; 2017; 44(2):581-593. PubMed ID: 29145193
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
11. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
12. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer.
Li X; Wang S; Li Z; Long X; Guo Z; Zhang G; Zu J; Chen Y; Wen L
Int J Biol Macromol; 2017 Dec; 105(Pt 1):346-353. PubMed ID: 28720546
[TBL] [Abstract][Full Text] [Related]
14. Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer.
Quan D; Chen K; Zhang J; Guan Y; Yang D; Wu H; Wu S; Lv L
J Cell Physiol; 2020 Apr; 235(4):3372-3381. PubMed ID: 31621912
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer.
Yong W; Yu D; Jun Z; Yachen D; Weiwei W; Midie X; Xingzhu J; Xiaohua W
Cell Death Dis; 2018 Aug; 9(9):861. PubMed ID: 30154460
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
[TBL] [Abstract][Full Text] [Related]
18. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
19. The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer.
Zhao L; Zhao Y; He Y; Li Q; Mao Y
Cell Signal; 2018 Nov; 51():152-165. PubMed ID: 30092355
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling.
Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B
Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
